| Yazarlar |
Doç. Dr. Özkan KOCAMIŞ
Kırşehir Ahi Evran Üniversitesi, Türkiye |
Emine Temel
Türkiye |
|
Gökçen Özcan
Türkiye |
|
Nazife Aşıkgarip
Türkiye |
Prof. Dr. Kemal ÖRNEK
Kırşehir Ahi Evran Üniversitesi, Türkiye |
| Özet |
| Purpose: To evaluate choroidal vascularity index (CVI) after a single dose of intravitreal dexamethasone implant in refractory diabetic macular oedema (DME). Methods: Total choroidal area, luminal area, and CVI were measured at baseline, 1st month, and at 3rd month after dexamethasone implant using binarization of enhanced depth imaging optical coherence tomography (EDI-OCT) images. Results: A total of 25 eyes of 25 patients (mean age: 61.4 +/- 8.3 years; 12 males, 13 females), were enroled in the study. All eyes had been previously treated with intravitreal aflibercept injections (mean number of injections 4.6 +/- 2.5). Mean CVI was 70.3 +/- 8.1 prior to intravitreal dexamethasone treatment. It was decreased to 66.1 +/- 9.3 at 1 month and 63.5 & PLUSMN; 10.1 at 3 months after treatment. The mean CVI was significantly decreased at 3 months compared with pre-treatment measures (p = 0.033). Conclusion: CVI was found to be decreased in patients who responded to intravitreal dexamethasone implant. |
| Anahtar Kelimeler |
| Aflibercept, Choroidal vascularity index, Dexamethasone, Diabetic macular oedema, Enhanced depth -optical coherence tomography |
| Makale Türü | Özgün Makale |
| Makale Alt Türü | SSCI, AHCI, SCI, SCI-Exp dergilerinde yayımlanan tam makale |
| Dergi Adı | Photodiagnosis and Photodynamic Therapy |
| Dergi ISSN | 1572-1000 |
| Dergi Tarandığı Indeksler | SCI-Expanded |
| Dergi Grubu | Q3 |
| Makale Dili | İngilizce |
| Basım Tarihi | 01-2022 |
| Makale Linki | https://www.sciencedirect.com/science/article/abs/pii/S1572100022002824?via%3Dihub |
